enVVeno Medical Statistics

Total Valuation

enVVeno Medical has a market cap or net worth of $7.24 million. The enterprise value is -$17.09 million.

Market Cap	7.24M
Enterprise Value	-17.09M

Important Dates

The next estimated earnings date is Thursday, July 30, 2026, before market open.

Earnings Date	Jul 30, 2026
Ex-Dividend Date	n/a

Share Statistics

enVVeno Medical has 667,669 shares outstanding. The number of shares has increased by 16.65% in one year.

Current Share Class	667,669
Shares Outstanding	667,669
Shares Change (YoY)	+16.65%
Shares Change (QoQ)	+5.96%
Owned by Insiders (%)	8.89%
Owned by Institutions (%)	7.03%
Float	486,208

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	0.78
PB Ratio	0.30
P/TBV Ratio	0.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.89, with a Debt / Equity ratio of 0.03.

Current Ratio	11.89
Quick Ratio	11.63
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -60.65% and return on invested capital (ROIC) is -39.30%.

Return on Equity (ROE)	-60.65%
Return on Assets (ROA)	-37.51%
Return on Invested Capital (ROIC)	-39.30%
Return on Capital Employed (ROCE)	-83.52%
Weighted Average Cost of Capital (WACC)	9.44%
Revenue Per Employee	n/a
Profits Per Employee	-$570,242
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.66% in the last 52 weeks. The beta is 1.09, so enVVeno Medical's price volatility has been similar to the market average.

Beta (5Y)	1.09
52-Week Price Change	-92.66%
50-Day Moving Average	10.78
200-Day Moving Average	15.30
Relative Strength Index (RSI)	52.91
Average Volume (20 Days)	8,769

Short Selling Information

The latest short interest is 70,022, so 10.49% of the outstanding shares have been sold short.

Short Interest	70,022
Short Previous Month	71,103
Short % of Shares Out	10.49%
Short % of Float	14.40%
Short Ratio (days to cover)	4.80

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-20.01M
Pretax Income	-18.82M
Net Income	-18.82M
EBITDA	-19.88M
EBIT	-20.01M
Earnings Per Share (EPS)	-$30.99

Full Income Statement

Balance Sheet

The company has $24.93 million in cash and $603,000 in debt, giving a net cash position of $24.33 million or $36.44 per share.

Cash & Cash Equivalents	24.93M
Total Debt	603,000
Net Cash	24.33M
Net Cash Per Share	$36.44
Equity (Book Value)	23.75M
Book Value Per Share	36.20
Working Capital	23.35M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.79 million and capital expenditures -$5,000, giving a free cash flow of -$14.79 million.

Operating Cash Flow	-14.79M
Capital Expenditures	-5,000
Depreciation & Amortization	127,000
Net Borrowing	n/a
Free Cash Flow	-14.79M
FCF Per Share	-$22.16

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

enVVeno Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.65%
Shareholder Yield	-16.65%
Earnings Yield	-260.01%
FCF Yield	-204.39%

Analyst Forecast

The average price target for enVVeno Medical is $437.50, which is 3,935.98% higher than the current price. The consensus rating is "Hold".

Price Target	$437.50
Price Target Difference	3,935.98%
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Splits

The last stock split was on January 20, 2026. It was a reverse split with a ratio of 1:35.

Last Split Date	Jan 20, 2026
Split Type	Reverse
Split Ratio	1:35

Scores

Altman Z-Score	n/a
Piotroski F-Score	1